Washington, DC 20006-5349
HELPLINE
The April 2017 issue of Translational Lung Cancer Research features an article titled Immunotherapy and radiation therapy for malignant pleural mesothelioma written by a group…
Michele Carbone, MD, PhD, Director of Thoracic Oncology at the University of Hawaii (UH) Cancer Center, along with his team, have discovered why people carrying…
The American Society of Clinical Oncology (ASCO) held its Annual Meeting on June 2-6, 2017 in Chicago. The Meso Foundation’s CEO, Melinda Kotzian, had the…
On June 5, Anna Nowak, MD, PhD, of the University of Western Australia and member of the Meso Foundation’s Science Advisory Board, presented phase II…
This morning, Arnaud Scherpereel, MD, PhD, head of the Pulmonary and Thoracic Oncology Department at the University Hospital of Lille in France, presented the results…
Mesothelioma is best known as the cancer associated with exposure to asbestos. A lesser known fact about mesothelioma is that the period between the exposure/s…
by Jadmin Mostel, Patient Support and Research Assistant, Mesothelioma Applied Research Foundation This past March, I attended the National Comprehensive Cancer Network (NCCN) annual conference,…
With the passage of the Omnibus budget bill last week, mesothelioma research will now be eligible for $60 million, an increase of $10 million over…
We recently spoke with mesothelioma nurse Colleen Norton, BSN, RN, of the University of Maryland to ask her some questions about her role in the…
We recently spoke with Melissa Culligan, RN, MS, a mesothelioma nurse at the University of Maryland and a member of the Meso Foundation’s Board of…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
